1. Home
  2. OPENZ vs GRMLW Comparison

OPENZ vs GRMLW Comparison

Compare OPENZ & GRMLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Opendoor Technologies Inc

OPENZ

Opendoor Technologies Inc

N/A

Current Price

$0.25

Market Cap

0.0

Sector

Finance

ML Signal

N/A

GRMLW

Greenland Mines Ltd Warrant

N/A

Current Price

$0.21

Market Cap

0.0

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OPENZ
GRMLW
Founded
N/A
N/A
Country
United States
United States
Employees
1042
5
Industry
Real Estate
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
OPENZ
GRMLW
Price
$0.25
$0.21
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
682.5K
28.3K
Earning Date
N/A
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.21
$0.10
52 Week High
$1.00
$0.38

Technical Indicators

Market Signals
Indicator
OPENZ
GRMLW
Relative Strength Index (RSI) 46.37 46.06
Support Level $0.22 N/A
Resistance Level $0.35 $0.38
Average True Range (ATR) 0.05 0.05
MACD 0.00 -0.01
Stochastic Oscillator 12.57 17.47

Price Performance

Historical Comparison
OPENZ
GRMLW

About OPENZ Opendoor Technologies Inc

Opendoor Technologies Inc is an end-to-end real estate platform enabling customers to sell and buy a home online. Its product offerings include Sell to Opendoor, its core product where sellers sell their homes directly to the company, and it resells those homes to buyers; List with Opendoor, for customers to list their homes with a partner agent; and Opendoor Marketplace, a capital-light marketplace offering that connects home sellers with both institutional and retail buyers. In addition to these products, the company also offers its customers integrated title insurance and escrow services through its subsidiaries. A vast majority of the company's revenue is generated by its core product offering, where it acquires homes directly from sellers and resells those homes to buyers.

About GRMLW Greenland Mines Ltd Warrant

Greenland Mines Ltd develops essential medicines for the treatment of chronic diseases - cancer, cardiovascular, and neurodegenerative disorders. The Company operates as a single reporting segment focused on developing essential medicines for these chronic diseases. The Company has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and proprietary patented technologies involving melanocortin receptor-binding molecules and a gene therapy platform that introduces a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases.

Share on Social Networks: